American Society of Clinical Oncology (ASCO)

The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, it has nearly 45,000 members worldwide.

Updated Results of the SOFT Study

ASCO 2014 – Colorectal and Head & Neck Cancer

mCRC Daily News from ASCO 2014: May 30, 2014 - Preview of Key Topics

ASCO 2014 – Colorectal and Head & Neck Cancer

Impact of p16 Status on Cetuximab + Radiotherapy in Locally Advanced SCCHN

ASCO 2014 – Colorectal and Head & Neck Cancer

This was a retrospective analysis of the phase 3 IMCL-9815 trial assessing the role of HPV-p16 status in patients with locally advanced SCCHN receiving radiation therapy (RT) plus cetuximab (cetux) or RT alone (Rosenthal DI, et al. ASCO 2014. Abstract 6001). Read More ›

BRAF + MEK Inhibitors in mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer

BRAF Inhibitor + Cetuximab in mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer

Second-Line Therapies in KRAS–Wild-Type mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer

A New Predictive Biomarker for Cetuximab—The New EPOC Trial

ASCO 2014 – Colorectal and Head & Neck Cancer

Pidilizumab in Relapsed Metastatic Melanoma

ASCO 2014 – Immuno-Oncology

Nivolumab and Erlotinib in EGFR-Mutation Positive Treatment-Resistant Advanced NSCLC

ASCO 2014 – Immuno-Oncology

Nivolumab in Chemotherapy-Naïve Advanced NSCLC

ASCO 2014 – Immuno-Oncology

Page 30 of 31

27
28
29
30
31

Conference Coverage Proudly Presented by

American Health & Drug Benefits

Journal of Hematology Oncology Pharmacy

Journal of Oncology Navigation & Survivorship

Oncology Practice Management

Personalized Medicine in Oncology

The Oncology Nurse–APN/PA

The Oncology Pharmacist

Value-Based Cancer Care

Learn more about our family of publications.

View Our Publications